DBVT – dbv technologies s.a. - american depositary shares (US:NASDAQ)
Stock Stats
News
1/19
01:53 am
dbvt
Low
Why DBV Technologies (ENXTPA:DBV) Is Up 21.7% After Extending Its VIASKIN Peanut Funding Runway [Yahoo! Finance]
1/18
06:11 am
dbvt
Low
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing [Yahoo! Finance]
1/16
06:11 pm
dbvt
Low
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
1/12
04:00 pm
dbvt
Medium
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
1/7
04:00 pm
dbvt
Medium
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
12/17
09:55 am
Maintains
Overweight
Overweight
Cantor Fitzgerald
Low
-2.4%
12/17
07:52 am
Maintains
Buy
Buy
Guggenheim
Medium
-6.5%
12/17
07:52 am
Maintains
Buy
Buy
Guggenheim
Medium
-6.5%
12/17
07:06 am
Reiterates
Buy
Buy
Guggenheim
Medium
-9.3%
12/17
07:06 am
Reiterates
Buy
Buy
Guggenheim
Medium
-9.3%
1/20
06:02 am
dbvt
Low
Form 8-K DBV Technologies S.A. For: Jan 16
1/14
05:36 pm
dbvt
Medium
Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: BAKER BROS. ADVISORS LP
1/14
04:33 pm
dbvt
Medium
Form 4 DBV Technologies S.A. For: Jan 12 Filed by: 667, L.P.
1/8
12:16 pm
dbvt
Low
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: JANUS HENDERSON GROUP PLC
1/7
04:01 pm
dbvt
Medium
Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: Bpifrance Participations SA
Show more
Top News Gainers
3/18 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Bryan, Garnier & Co from a "buy" rating to a "neutral" rating. 27.9%
3/17 Monthly information regarding the total number of voting rights and  total number of shares of the Company as of February 29, 2020 and March 4, 2020 25.8%
1/8 DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy 14.8%
4/21 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 14.1%
4/14 Form 6-K DBV Technologies S.A. For: Apr 13 13.6%
4/7 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.25 price target on the stock. 10.6%
7/3 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 10.2%
8/7 DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy 9.5%
2/26 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.7%
4/15 Monthly information regarding the total number of voting rights and total number of shares of the Company 5.8%
Top News Decliners
3/10 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.25 price target on the stock. -14.2%
1/29 Form 6-K DBV Technologies S.A. For: Jan 29 -13.2%
3/12 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -11.7%
3/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Kepler Capital Markets from a "buy" rating to a "hold" rating. -11.6%
12/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock. -8.7%
2/4 Form 6-K DBV Technologies S.A. For: Feb 04 -8.6%
3/5 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $18.00 price target on the stock. -8.5%
1/9 Form 6-K DBV Technologies S.A. For: Jan 08 -8.4%
10/9 DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares -8.2%
4/14 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.75 price target on the stock. -8.2%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3